Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEkf Diagnostics Regulatory News (EKF)

Share Price Information for Ekf Diagnostics (EKF)

Share Price is delayed by 15 minutes
Get Live Data
25.80    -1.20 (-4.44%)
Bid:
25.60
Ask:
26.20
Spread: 0.60 (2.344%)
Market Cap: £111.01m
EKF Live PriceLast checked at - London Stock Exchange

Intraday Ekf Diagnostics Share Chart

Cancellation of share options

26 Jun 2017 07:00

RNS Number : 0676J
EKF Diagnostics Holdings PLC
26 June 2017
 

EKF Diagnostics Holdings plc

("EKF", the "Company")

 

Cancellation of share options

 

EKF Diagnostics Holdings plc (AIM: EKF), the AIM listed point-of-care business, announces that 21,614,766 share options over ordinary shares of 1 penny each (the "Ordinary Shares") granted to certain directors, PDMRs, employees and the former Chairman of the Company (the "Options") have been cancelled at the election of those holding the options (the "Optionholders") in return for the payment of a one-off cash sum.

 

Details of the cancellation of the Options are set out below:

 

PDMR

Role

Number of Options being surrendered

Cash payment (£)

Julian Baines

CEO

5,127,383

354,348

Richard Evans

COO and CFO

4,260,000

294,826

Steven Wray

Head of Sales EMEA

825,000

61,801

Gilbert Mejia

Head of Sales Americas

800,000

60,522

Martyn Lewis

Head of Marketing

800,000

61,551

Peter Coyne

Head of Operations

800,000

61,551

Ed Hitchler

General Manager, EKF USA

800,000

59,914

Steffen Borlich

General Manager, EKF Germany

800,000

61,893

Salim Hamir

Company Secretary and Head of Corporate Affairs

600,000

46,802

Colin Anderson

Deputy Finance Director

700,000

46,802

Other employees and the former Chairman

Various

6,102,383

395,331

Total

21,614,766

1,505,341

 

The cash sum to be paid to each relevant Optionholder has been calculated by reference to the mid-market share price of 21.5p, being the price at the time the offer was made to the Optionholders, with certain tax and other adjustments being applied.

 

The purpose of this cancellation is to try and simplify the Company's capital structure ahead of the previously announced intended proposed share buyback and to reduce future dilution to shareholders.

 

Following the cancellation, share options remain over a total of 1,950,000 Ordinary Shares and these are exercisable at various prices of between 20p and 37.625p and expire between 7 July 2023 and 6 April 2025.

 

As at 23 June 2017 the Company had net cash balances of approximately £3.9m after deduction of the £1.5m to be paid to the various Optionholders as set out above.

 

EKF Diagnostics Holdings plc 

www.ekfdiagnostics.com

Christopher Mills, Non-Executive Chairman

Tel: 029 2071 0570

Julian Baines, CEO 

Richard Evans, FD & COO

N+1 Singer (Nomad & Broker)

Tel: 020 7496 3000

Alex Price / Shaun Dobson / Ali Laughton-Scott

Walbrook PR Limited

Tel: 020 7933 8780 or ekf@walbrookpr.com

Paul McManus / Lianne Cawthorne

Mob: 07980 541 893 / 07584 391 303

 

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.

 

 1

 

Details of the person discharging managerial responsibilities / person closely associated 

 

 

a)

 

Names 

Julian Baines - Chief Executive Officer

Richard Evans - Chief Operating Officer and Finance Director

Steven Wray - Head of Sales EMEA

Gilbert Mejia - Head of Sales Americas

Martyn Lewis - Head of Marketing

Peter Coyne - Head of Operations

Ed Hitchler - General Manager, EKF USA

Steffen Borlich - General Manager, EKF Germany

Salim Hamir - Company Secretary and Head of Corporate Affairs

Colin Anderson - Deputy Finance Director

2

 

Reason for the notification

a)

 

Position/status

 

See 1(a) above for positions - all classified as PDMRs of EKF

b)

 

Initial notification /Amendment

Initial Notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor 

a)

 

Name

 

EKF Diagnostics Holdings plc

b)

 

LEI

213800DXTF3EAUK1AR05

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument 

In each case, the grant of Options over Ordinary Shares

b)

Identification code 

GB0031509804

c)

 

Nature of the transaction 

Cancellation of Options over Ordinary Shares 

d)

 

Price(s) and volume(s)

Price - n/a

Volume(s)

Julian Baines - 5,127,383 Options

Richard Evans - 4,260,000 Options

Steven Wray - 825,000 Options

Gilbert Mejia - 800,000 Options

Martyn Lewis - 800,000 Options

Peter Coyne - 800,000 Options

Ed Hitchler - 800,000 Options

Steffen Borlich - 800,000 Options

Salim Hamir -600,000 Options

Colin Anderson - 700,000 Options

 

d)

 

Aggregated information 

- Aggregated volume

- Price

 

15,512,383

N/A

e)

 

Date of the transaction 

26 June 2017

f)

 

Place of the transaction

Outside a trading venue

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHEASKDALFXEFF
Date   Source Headline
15th Jun 202612:36 pmRNSShare Buyback
12th Jun 20267:00 amRNSShare Buyback
11th Jun 20267:00 amRNSShare Buyback
20th May 20265:41 pmRNSLong Term Incentive Plan Award
19th May 202612:24 pmRNSResult of AGM
19th May 20267:00 amRNSAGM statement & positive Q1 trading update
27th Apr 20267:00 amRNSBoard Changes
24th Apr 20264:43 pmRNSPosting of Annual Report & Notice of AGM
13th Apr 20267:00 amRNSAcquisition of assets from Beep Insights
10th Apr 20269:12 amRNSShare Buyback
8th Apr 20262:33 pmRNSShare Buyback
7th Apr 20261:09 pmRNSShare Buyback
2nd Apr 20267:00 amRNSShare Buyback
31st Mar 20265:59 pmRNSShare Buyback
24th Mar 20267:00 amRNSFull year results
20th Mar 202611:25 amRNSShare Buyback
19th Mar 202611:20 amRNSShare Buyback
19th Mar 20267:00 amRNSHolding(s) in Company
18th Mar 20269:58 amRNSShare Buyback
6th Mar 20267:00 amRNSShare Buyback
5th Mar 20267:00 amRNSNotice of Results
3rd Mar 20267:00 amRNSThree-year Hematology purchasing agreement
2nd Mar 20263:30 pmRNSTotal Voting Rights
27th Feb 20267:00 amRNSShare Buyback
19th Feb 20267:00 amRNSShare Buyback Programme
2nd Feb 20267:00 amRNSShare Buyback & Completion of Buyback Programme
30th Jan 20267:00 amRNSShare Buyback
29th Jan 20267:00 amRNSShare Buyback
28th Jan 202611:41 amRNSShare Buyback
27th Jan 20267:00 amRNSFY 2025 Trading Update
15th Jan 20267:00 amRNSShare Buyback
14th Jan 202611:43 amRNSShare Buyback
14th Jan 20269:37 amRNSShare Buyback
12th Jan 20269:45 amRNSShare Buyback
9th Jan 20265:00 pmRNSShare Buyback
8th Jan 20269:40 amRNSShare Buyback
6th Jan 20266:03 pmRNSShare Buyback
2nd Jan 202610:23 amRNSShare Buyback
31st Dec 202510:45 amRNSShare Buyback
31st Dec 202510:45 amRNSShare Buyback
30th Dec 20257:00 amRNSShare Buyback
30th Dec 20257:00 amRNSShare Buyback
29th Dec 20257:00 amRNSShare Buyback
29th Dec 20257:00 amRNSShare Buyback
24th Dec 202510:43 amRNSShare Buyback
24th Dec 202510:43 amRNSShare Buyback
23rd Dec 20255:23 pmRNSShare Buyback
23rd Dec 20255:23 pmRNSShare Buyback
22nd Dec 202511:10 amRNSShare Buyback
22nd Dec 202511:10 amRNSShare Buyback

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.